Obi Light Ogbonnia: The Power of Lived Experience in Health Policy and Research
Obi Light Ogbonnia, Founder and President of Sickle Cell Foundation and Chief Executive Officer at VTN Global Resources Limited, shared a post on LinkedIn:
“The Power of Lived Experience in Health Policy and Research
There is a hard truth many systems still struggle to admit:
You cannot design effective health policies for patients without listening to the people who live with the condition every day.
For years, research papers have been written and policies designed in boardrooms far removed from hospital wards and patient homes. Experts analyze statistics, governments design programmes, and organizations launch interventions.
Yet many of these interventions fall short.
Not because the experts lack knowledge, but because the people most affected were rarely involved in shaping the solutions.
This is why patient-led organizations matter.
Data can tell us how many people are living with a condition.
But data alone cannot explain the daily reality.
- It cannot fully capture the stigma a patient faces in society.
- It cannot show the difficult choices families make between food and medication.
- It cannot describe the emotional and physical battles patients fight quietly every day.
Lived experience fills this gap.
Patient communities often understand the weaknesses of the system long before policymakers see them. They know where access fails, where support is missing, and what solutions are truly practical.
Across the world, healthcare outcomes improve when patient voices are part of the conversation.
Patient-led organizations help to:
- identify urgent needs faster
- build trust within communities
- guide more relevant research
- strengthen accountability
- humanize policies and programmes
Behind many of these organizations are individuals who turned personal pain into purpose. People who could have remained silent but chose to advocate so others might suffer less.
Their voices bring truth to the table.
As governments, researchers, NGOs and institutions plan the future of healthcare, one lesson is becoming clear:
Patients should not only be beneficiaries of policies.
They must be partners in shaping them.
I would also like to sincerely acknowledge the organizers of the Inherited Blood Disorders Leadership Forum recently held in Abuja for creating a platform that brought together researchers, policymakers, healthcare professionals, and patient advocates for meaningful dialogue.
Creating spaces where lived experience meets policy is how real progress begins.
The future of healthcare will be stronger when it is built with patients, not just for them.”

Stay updated with Hemostasis Today.
-
Apr 12, 2026, 22:12Maciej Banach: The ‘Metastatic’ Cardiovascular Threat We Can No Longer Ignore
-
Apr 12, 2026, 21:52Umar Jawed: The Most Dangerous Anti-D Result Is Not the Highest One – It’s the One You Underestimate Early
-
Apr 12, 2026, 21:37Demosthenes Panagiotakos: Hellenic Atherosclerosis Society Calls for Papers on Innovative Strategies in Atherosclerotic Plaque Management
-
Apr 12, 2026, 21:24Heghine Khachatryan: Diagnosing PNH in Resource-Limited Settings
-
Apr 12, 2026, 21:15Katariina Öörni: Role of Cholesterol Absorption Efficiency in Atherosclerosis
-
Apr 12, 2026, 17:34Caitlin Raymond: Granulocyte Transfusions for the Overworked Fellow
-
Apr 12, 2026, 17:33Augustina Isioma Ikusemoro: ABO Typing Is Not the Same in Infants and Adults
-
Apr 12, 2026, 17:32Bastu Odoka: Same Blood Group Does Not Guarantee Compatibility
-
Apr 12, 2026, 17:31Jack Hadfield: SARS-CoV-2–Associated Lasting Mitochondrial Injury in Cardiomyocytes